ITI

Sun Pharma make speciality pharmaceuticals and active pharmaceutical ingredients. Sun Pharma's brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. Sun Pharma have the same drive for growth that marked our early days. Sun Pharma came into existence as a startup with just 5 products in 1983. In the time since, we have crossed several milestones to emerge as a leading pharma company in India, a rank that we have now been at for more than 5 years. (IMS-ORG Retail Store Audit, March 2006.

Troikaa Pharma is a leading company with the remarkable ability to constantly innovate through creative Imagination. Our NDDS brands Dynapar AQ and Dynapar QPS are path breaking & have revolutionised pain care. These innovative products are backed by strong global patents. Continuous focus on innovation and an unwavering commitment to quality has helped Troikaa establish itself both in domestic and international markets. The company is driven by a visionary leadership and a strong multicultural workforce representing more than 70 countries. It's state-of-the-art manufacturing facilities located at Thol, Dehradun and Sanand are accredited by global authorities including WHO, PIC/S, ANVISA Brazil, INVIMA & several other regulatory authorities.

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.

Sun Pharma is the fifth largest generic pharmaceutical company in the world. It is also Indias largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high-quality medicines trusted by customers and patients in over 150 countries and has multiple manufacturing facilities and R & D centres. Our leadership is approachable, recognizes peoples passion for growth, gives them a voice and empowers them to make a positive change. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Dadra, U.T. of D. & N. H.(Near Silvassa & Vapi).

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.  Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. (as per IMS Health India, Secondary Stockiest Audit (SSA), Nov 16, 2016 MAT).

Sun Pharma is the fifth largest generic pharmaceutical company in the world. It is also Indias largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high-quality medicines trusted by customers and patients in over 150 countries and has multiple manufacturing facilities and R & D centres. Our leadership is approachable, recognizes peoples passion for growth, gives them a voice and empowers them to make a positive change.

Hetero Drugs established in the year 1993, with the motto to be the best in the API manufacturing, Hetero today embodies the vision of a top notch player in developing and commercialising products catering to a variety of therapeutic categories, integrating into a leading finished dosage manufacturer. True to the Statement, "Where the Future Started Yesterday", with a foresight on the current trends in the Pharmaceutical Market, Hetero has grown from strength to strength, combining its Research Strengths, Manufacturing Capabilities ,Human Resources and well established quality management system.

Bharat Biotech creates innovative vaccines and bio-therapeutics trusted by physicians around the world. We own 160 global patents and our products help people in over 65 countries live to their fullest potential. Our manufacturing facilities are approved by USFDA, KFDA and WHO.

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.